Literature DB >> 11591859

Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK.

N P Davies1, L H Eunson, M Samuel, M G Hanna.   

Abstract

Eleven of 36 families with hypokalemic periodic paralysis (hypoPP) harbored mutations in the skeletal muscle calcium channel gene (CACNA1S). The authors screened the skeletal muscle sodium channel gene (SCN4A) in the remainder. One family harbored a new heterozygous point mutation C2014A in exon 12 (R672S) of SCN4A. The authors identified the genetic defect underlying hypoPP in 33% of individuals tested. The authors conclude that SCN4A mutations are an uncommon cause of hypoPP in this UK population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591859     DOI: 10.1212/wnl.57.7.1323

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Voltage-sensor mutations in channelopathies of skeletal muscle.

Authors:  Stephen C Cannon
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

Review 2.  Neurological channelopathies.

Authors:  T D Graves; M G Hanna
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

Review 3.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 4.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

5.  Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.

Authors:  Valeria A Sansone; James Burge; Michael P McDermott; Patty C Smith; Barbara Herr; Rabi Tawil; Shree Pandya; John Kissel; Emma Ciafaloni; Perry Shieh; Jeffrey W Ralph; Antony Amato; Steve C Cannon; Jaya Trivedi; Richard Barohn; Brian Crum; Hiroshi Mitsumoto; Alan Pestronk; Giovanni Meola; Robin Conwit; Michael G Hanna; Robert C Griggs
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

6.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

7.  Pathophysiological role of omega pore current in channelopathies.

Authors:  Karin Jurkat-Rott; James Groome; Frank Lehmann-Horn
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

8.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

9.  Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.

Authors:  E Matthews; R Labrum; M G Sweeney; R Sud; A Haworth; P F Chinnery; G Meola; S Schorge; D M Kullmann; M B Davis; M G Hanna
Journal:  Neurology       Date:  2008-12-31       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.